Abstract
Leishmaniasis is a parasitic disease caused by Leishmania, transmitted by the bite of some sandfly species. It is endemic in 88 countries throughout the world. Pentavalent antimonials are the standard therapy for leismaniasis. Saffron (crocus sativus) belongs to the iridaceae family. This paper will outline the benefits and challenges of repurposing saffron for treating leishmaniasis.
Keywords: Crocus sativus, cardiotoxicity, leishmaniasis, saffron, pathogenesis, treatment.
Infectious Disorders - Drug Targets
Title:Can Saffron (Crocus sativus) be Effective in the Treatment of Leishmaniasis?
Volume: 13 Issue: 5
Author(s): Nooshin Bagherani
Affiliation:
Keywords: Crocus sativus, cardiotoxicity, leishmaniasis, saffron, pathogenesis, treatment.
Abstract: Leishmaniasis is a parasitic disease caused by Leishmania, transmitted by the bite of some sandfly species. It is endemic in 88 countries throughout the world. Pentavalent antimonials are the standard therapy for leismaniasis. Saffron (crocus sativus) belongs to the iridaceae family. This paper will outline the benefits and challenges of repurposing saffron for treating leishmaniasis.
Export Options
About this article
Cite this article as:
Bagherani Nooshin, Can Saffron (Crocus sativus) be Effective in the Treatment of Leishmaniasis?, Infectious Disorders - Drug Targets 2013; 13 (5) . https://dx.doi.org/10.2174/1871526514666140217145454
DOI https://dx.doi.org/10.2174/1871526514666140217145454 |
Print ISSN 1871-5265 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3989 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of Viruses in Neurodegenerative and Neurobehavioral Diseases
CNS & Neurological Disorders - Drug Targets Current Constructs and Targets in Clinical Development for Antibody- Based Cancer Therapy
Current Drug Targets Therapeutic Targeting of Chemokines with Monoclonal Antibodies
Current Immunology Reviews (Discontinued) Update on the Biologic Role of the Vitamin D Endocrine System
Current Vascular Pharmacology Retinoid Related Molecules an Emerging Class of Apoptotic Agents with Promising Therapeutic Potential in Oncology: Pharmacological Activity and Mechanisms of Action
Current Pharmaceutical Design Fcγ Receptor 1 (CD64), a Target Beyond Cancer
Current Pharmaceutical Design Editorial [Hot-Topic: Molecular Mechanisms in Rheumatic Diseases:Rationale for Novel Drug Development (Guest Editor: Charles J. Malemud)]
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Arachidonate Cascade in the Intensive Insulin Therapy for Critically Ill Patients with Sepsis: Roles of Prostaglandins on Hyperglycemia-Impaired Immunity
Letters in Drug Design & Discovery Insights into the Role of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinases in Health and Disease
Current Chemical Biology Matrix Metalloproteinases in Vascular Disease - A Potential Therapeutic Target?
Current Vascular Pharmacology Development and In Vitro Evaluation of Ketoprofen Extended Release Pellets Using Powder Layering Technique in a Rotary Centrifugal Granulator
Combinatorial Chemistry & High Throughput Screening The Role of Foxp3 in Regulatory T Cell Differentiation and Function
Current Immunology Reviews (Discontinued) Cancer Vaccines for Hormone/Growth Factor Immune Deprivation:A Feasible Approach for Cancer Treatment
Current Cancer Drug Targets Patent Selections:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Current Advances in Therapy for Metastatic Melanoma
Current Cancer Therapy Reviews Dietary Nitrite in Nitric Oxide Biology: A Redox Interplay with Implications for Pathophysiology and Therapeutics
Current Drug Targets Carbohydrate-Based Drugs in the Treatment of Epilepsy, Depression and Other Affective Disorders
Current Topics in Medicinal Chemistry Biomarker Diversity, Validation and Clinical Translation: Tenets for Emergent Personalized Medicine Initiatives
Current Pharmacogenomics and Personalized Medicine Quilizumab is an Afucosylated Humanized Anti-M1 Prime Therapeutic Antibody
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) Inflammatory Biomarkers and Atrial Fibrillation: Potential Role of Inflammatory Pathways in the Pathogenesis of Atrial Fibrillation-induced Thromboembolism
Current Vascular Pharmacology